samedan logo
 
 
 
spacer
home > ebr > spring 2003 > the meuse-rhine triangle
PUBLICATIONS
European Biopharmaceutical Review

The Meuse-Rhine Triangle

'Getting it together' as the phrase goes - at least as regards brainpower, money and business experience for the purpose of life science enterprise - is not always easy. The Meuse-Rhine Euroregion is an area, however, in which the much-derided EU bureaucracy does provide more than a glimmer of hope.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Stafford Wadsworth, Editor and Publisher of the Meuse-Rhine Journal

Stafford Wadsworth, a former Editor-in-Chief of Limburg International Magazine and the Editor and Publisher of the Meuse-Rhine Journal, is a British business journalist based in Maastricht, covering business news in the Meuse-Rhine Euroregion. He regularly writes for economic development agencies in Aachen, Liège and Maastricht, in particular for the Limburg Development Company LIOF, and has edited a number of life science-dedicated publications.

Stafford graduated with first class honours in Oriental Languages from the University of British Columbia and undertook graduate work in Linguistics at the Universities of Washington and Edinburgh.

spacer
Stafford Wadsworth
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Expands eCOA Solution for Higher Fidelity CNS Assessments

ERT, the global leader in clinical endpoint data collection, today announced a preferred partnership with the leading neuroscience technology company, Cogstate, Ltd. The collaboration enables ERT to expand its industry-leading electronic Clinical Outcome Assessment (eCOA) solution with digital cognitive endpoint measurement to improve safety and efficacy assessment in clinical trials, including capabilities for at-home testing.
More info >>

White Papers

Device Develop for Combo Products

Phillips-Medisize

Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement